患者感知的肝细胞癌风险与监测净获益:一项多中心调查研究
在美国7个卫生系统对成人肝硬化患者开展调查(n=665),评估其对肝细胞癌监测的知识、态度和感知风险。多数患者了解监测益处并愿意接受监测,但约五分之一存在知识缺口,且仅54.2%回忆医生讨论过监测危害。
要点
- 80.3%患者认为监测可提高肝细胞癌早期检出,77.9%认为可改善生存。
- 仅54.2%患者回忆医生讨论过监测潜在危害,74.0%回忆讨论过益处。
- 基于图示当前监测获益与危害估计,93.2%患者选择接受监测。
核心结论
- 多数在学术卫生系统随访的肝硬化患者对肝细胞癌监测知识水平高,认为其有益,并在被告知获益与危害后表示愿意接受监测。
研究设计与样本
- 在美国7个卫生系统对成人肝硬化患者开展的调查研究,共纳入665例受访者,中位年龄60岁,46.5%为女性。
主要发现
- 受访者对肝细胞癌监测知识丰富,各社会人口学组间无显著差异,但约五分之一患者对监测的必要性和益处存在知识缺口。
- 超过四分之三患者认为监测可改善肝细胞癌早期检出(80.3%)和生存(77.9%)。
- 74.0%患者报告医生讨论过监测益处,仅54.2%回忆讨论过潜在危害。
- 患者更重视监测益处,但表示评估监测项目净获益时应测量危害。
- 基于展示当前监测获益与危害估计的图示,93.2%患者选择接受监测,按种族、感知监测益处或对死于肝细胞癌的恐惧分组均无显著差异。
局限性
- 研究局限性包括应答偏倚和无应答偏倚,可能导致对报告的监测益处和患者接受度的估计偏高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hepatocellular carcinoma (HCC) surveillance is underused in clinical practice, and few contemporary data have assessed patients' perceptions of surveillance effectiveness and net benefit. METHODS: We conducted a survey study among adult patients with cirrhosis at 7 health systems in the United States. The survey was based on validated measures, when available, and assessed patient knowledge about HCC surveillance, attitudes regarding surveillance benefits and harms, perceived HCC risk, and trust in their doctors. RESULTS: Respondents (n = 665; median age 60; 46.5% female) were knowledgeable about HCC surveillance, with no significant differences across sociodemographic groups; however, approximately 1 in 5 patients had knowledge gaps about the need and benefit of surveillance. Over three fourths of patients believed that surveillance improves early HCC detection (80.3%) and survival (77.9%). While 74.0% of patients reported that doctors had discussed surveillance benefits, only 54.2% recalled a discussion about potential harms. Patients placed greater importance on surveillance benefits, but expressed harms should be measured when assessing the net benefit of surveillance programs. Based on a pictogram depicting current estimates for surveillance benefits and harms, 93.2% of patients chose to undergo surveillance, with no significant differences by race, perceived surveillance benefits, or fear of dying from HCC. Study limitations include response and nonresponse biases, which may result in an overestimation of reported surveillance benefits and patient acceptance. DISCUSSION: Most patients with cirrhosis followed at academic health systems have high knowledge about HCC surveillance, believe that it is beneficial, and express interest in undergoing surveillance after being counseled about the benefits and harms.
引用
- Singal AG, Yang JD, Jalal PK, et al. Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study. Am J Gastroenterol. 2025. PMID: 40267274. doi:10.14309/ajg.0000000000003494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。